Company Samsung Biologics Co.,Ltd.

Equities

A207940

KR7207940008

Pharmaceuticals

End-of-day quote Korea S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
833,000 KRW -0.36% Intraday chart for Samsung Biologics Co.,Ltd. -2.80% +9.61%

Business Summary

Samsung Biologics Co Ltd is a Korea-based company primarily engaged in development, manufacture and distribution of biological products. The Company, as a contract manufacturing organization (CMO), mainly develops and manufactures antibody drugs used for treatment of cancer, autoimmune disease, diabetes and chronic diseases. It also provides cell line development and process development services. The Company distributes its products in domestic and overseas markets.

Number of employees: 4,284

Sales per Business

KRW in Million2022Weight2023Weight Delta
Contract Development and Manufacturing Organization
72.4 %
2,337,523 77.9 % 2,674,291 72.4 % +14.41%
Biopharmaceutical Development and Commercialization
27.6 %
663,772 22.1 % 1,020,298 27.6 % +53.71%

Sales per region

KRW in Million2022Weight2023Weight Delta
Europe
63.7 %
1,785,875 59.5 % 2,353,845 63.7 % +31.80%
Americas
26.3 %
853,984 28.5 % 971,055 26.3 % +13.71%
Other
6.9 %
206,690 6.9 % 255,120 6.9 % +23.43%
South Korea
3.1 %
154,746 5.2 % 114,569 3.1 % -25.96%

Managers

Managers TitleAgeSince
Chief Executive Officer 62 17-12-31
Director of Finance/CFO - -
Chairman 66 11-04-20
Chief Tech/Sci/R&D Officer 56 -
Compliance Officer 54 16-12-31
Director/Board Member 59 -
Public Communications Contact 57 13-12-31
General Counsel - 23-08-22
Corporate Officer/Principal - 20-12-31
Human Resources Officer - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 70 -
Chairman 66 11-04-20
Director/Board Member 62 -
Director/Board Member 69 -
Director/Board Member 59 -
Director/Board Member 59 -
Director/Board Member 68 19-03-21
Chief Executive Officer 62 17-12-31
Director/Board Member 65 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 71,174,000 17,955,087 ( 25.23 %) 0 25.23 %

Shareholders

NameEquities%Valuation
30,646,705 43.06 % 17 814 M ₩
22,217,309 31.22 % 12 914 M ₩
National Pension Service of Korea
6.677 %
4,752,024 6.677 % 2 762 M ₩
Candriam SCA
0.0848 %
60,374 0.0848 % 35 M ₩
Sjunde AP-fonden
0.0523 %
37,231 0.0523 % 22 M ₩
State Street Global Advisors Ltd.
0.0496 %
35,278 0.0496 % 21 M ₩
Goldman Sachs Asset Management International
0.0447 %
31,824 0.0447 % 18 M ₩
Aberdeen Asset Management (Thailand) Co., Ltd.
0.0399 %
28,416 0.0399 % 17 M ₩
Union Investment Privatfonds GmbH
0.0249 %
17,750 0.0249 % 10 M ₩
Storebrand Asset Management AS
0.0239 %
17,035 0.0239 % 10 M ₩

Company contact information

SAMSUNG BIOLOGICS Co., Ltd.

300 Songdo Bio Way Yeonsu-gu

21987, Inchon

+

http://www.samsungbiologics.com
address Samsung Biologics Co.,Ltd.(A207940)